Literature DB >> 26193357

A case of congenital chloride diarrhea: information obtained through long-term follow-up with reduced electrolyte substitution.

Shigeo Iijima1, Takehiko Ohzeki2.   

Abstract

Congenital chloride diarrhea (CCD) is an inherited disorder of intestinal electrolyte transport that results in a large wastage of electrolytes and water. The patient, who is now 24 years old, was diagnosed at the age of 16 months with CCD based on hypochloremic alkalosis, hyponatremia, and hypokalemia with increased plasma renin and aldosterone levels, and high fecal Cl(-). Serum Na(+) and plasma aldosterone levels were normalized by replacement therapy with NaCl [8 mmol/(kg day)] and KCl [3 mmol/(kg day)]. On follow-up, watery diarrhea persisted, and she was frequently noted to have hypokalemia despite normal serum Na(+) and Cl(-) and plasma aldosterone levels with only reduced dosages of KCl [1-1.5 mmol/(kg day)] substitution due to only sporadic ambulatory care and unsatisfactory compliance with medication, and a normal diet. However, she had acceptable growth, normal renal function, and had an uneventful pregnancy and delivery of a healthy child. In adolescence and adulthood, hypokalemia may be the main problem requiring treatment, and substitution therapy with adequate doses of KCl alone may be sufficient, although a combination of NaCl and KCl is generally recommended even after childhood.

Entities:  

Keywords:  Congenital chloride diarrhea; Hypokalemia; Long-term follow-up; Reduced substitution

Year:  2008        PMID: 26193357     DOI: 10.1007/s12328-008-0005-4

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  11 in total

1.  Proton-pump inhibition of gastric chloride secretion in congenital chloridorrhea.

Authors:  B W Aichbichler; C H Zerr; C A Santa Ana; J L Porter; J S Fordtran
Journal:  N Engl J Med       Date:  1997-01-09       Impact factor: 91.245

2.  The renal lesion in congenital chloride diarrhea.

Authors:  C Holmberg; J Perheentupa; A Pasternack
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

3.  Distinct outcomes of chloride diarrhoea in two siblings with identical genetic background of the disease: implications for early diagnosis and treatment.

Authors:  P Höglund; C Holmberg; P Sherman; J Kere
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

4.  Long-term clinical outcome in patients with congenital chloride diarrhea.

Authors:  Satu Hihnala; Pia Höglund; Laura Lammi; Jorma Kokkonen; Timo Ormälä; Christer Holmberg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-04       Impact factor: 2.839

5.  Hypertensive angiopathy in familial chloride diarrhea.

Authors:  A Pasternack; J Perheentupa
Journal:  Lancet       Date:  1966-11-12       Impact factor: 79.321

6.  Cholestyramine in treatment of congenital chloride diarrhoea.

Authors:  J R Brocklehurst; A C Walker
Journal:  Med J Aust       Date:  1978-05-06       Impact factor: 7.738

7.  Congenital chloride diarrhoea. Clinical analysis of 21 Finnish patients.

Authors:  C Holmberg; J Perheentupa; K Launiala; N Hallman
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

8.  Congenital chloride diarrhoea.

Authors:  C Holmberg
Journal:  Clin Gastroenterol       Date:  1986-07

9.  Electrolyte economy and its hormonal regulation in congenital chloride diarrhea.

Authors:  C Holmberg
Journal:  Pediatr Res       Date:  1978-02       Impact factor: 3.756

10.  Butyrate as an effective treatment of congenital chloride diarrhea.

Authors:  Roberto Berni Canani; Gianluca Terrin; Pia Cirillo; Giuseppe Castaldo; Francesco Salvatore; Giuseppe Cardillo; Anna Coruzzo; Riccardo Troncone
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

View more
  1 in total

1.  Congenital chloride diarrhea clinical features and management: a systematic review.

Authors:  Lavinia Di Meglio; Giuseppe Castaldo; Caterina Mosca; Andrea Paonessa; Monica Gelzo; Maria Valeria Esposito; Roberto Berni Canani
Journal:  Pediatr Res       Date:  2020-11-10       Impact factor: 3.756

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.